Malaria incidence and prevention among European and North American travellers to Kenya.
A longitudinal survey was conducted among travellers departing from Nairobi airport to determine the use of malaria prevention measures and assess the risk for malaria while travelling in Kenya. Among 5489 European and North American travellers, 68 different drug regimens were used for prophylaxis, and 48% of travellers used both regular chemoprophylaxis and more than 1 antimosquito measure during travel; 52% of 3469 travellers who used chemoprophylaxis did so without interruption during their travel and for 4 weeks after departure. Compliance was lowest among travellers who visited friends and relatives, who were young, or who stayed more than 3 weeks. Sixty-seven (1%) travellers experienced symptoms of malaria, but the diagnosis could be verified for only 16 of these. Long-stay travellers appeared to be at higher risk for malaria than short-stay travellers, and health information needs to be targeted especially to the former. Similar investigations are needed among international travellers to other malaria-endemic countries. With comparable data available, consistent and effective malaria prevention guidelines can be developed.
Lobel
H O
HO
Division of Parasitic Diseases, Centers for Disease Control, Atlanta, GA 30333.
Phillips-Howard
P A
PA
Brandling-Bennett
A D
AD
Steffen
R
R
Campbell
C C
CC
Huong
A Y
AY
Were
J B
JB
Moser
R
R
D000328:Adult; D000367:Age Factors; D000962:Antimalarials / Q000627:therapeutic use*; D005060:Europe / Q000453:epidemiology / Q000208:ethnology; D006801:Humans; D007630:Kenya; D008137:Longitudinal Studies; D008288:Malaria / Q000453:epidemiology* / Q000517:prevention & control; D008875:Middle Aged; D009656:North America / Q000453:epidemiology / Q000208:ethnology; D010349:Patient Compliance; D014195:Travel
D000962:Antimalarials